By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Live Trading NewsLive Trading NewsLive Trading News
  • Stocks
  • Forex
  • Gold
  • KNIGHTS
  • Luxury
  • Horse Racing
  • Trade Now
Search
Reading: Sitting on a Cash Pile 17.0? Innovative Cancer Biotech in Focus
Share
Live Trading NewsLive Trading News
  • Stocks
  • Forex
  • Gold
  • KNIGHTS
  • Luxury
  • Horse Racing
  • Trade Now
Search
  • Stocks
  • Forex
  • Gold
  • KNIGHTS
  • Luxury
  • Horse Racing
  • Trade Now
Follow US
© 2024 LiveTradingNews.com - All Rights Reserved.
Live Trading News > Blog > Paul Ebeling > Sitting on a Cash Pile 17.0? Innovative Cancer Biotech in Focus
Paul Ebeling

Sitting on a Cash Pile 17.0? Innovative Cancer Biotech in Focus

Paul Ebeling
Last updated: September 29, 2021 6:13 am
Paul Ebeling
Share
2 Min Read
SHARE

#cash#bullish#buy

$PBYI

Puma Biotechnology Inc. (NASDAQ:PBYI) reversed on 21 September and broke out on 27 September at 7.12/share. Thus triggering an LTN Cash Pile Buy signal with a 1 yr target price of 23.24.

Wednesday, Citigroup upgraded the shares from Neutral to Buy with an 11 price target. The consensus target is at 8.63.

The Key support is at 7.15 and the Major resistance is at 11.60, 2 of our Key technical indicators have turned Very Bullish, and our outlook is Neutral with a Very Bullish long term bias.

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

The company’s drug candidates include PB272 neratinib (oral) for the adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors.

It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd.

The company was founded in Y 2010 and is HQ’d in Los Angeles, California.

Have a prosperous day, Keep the Faith!

You Might Also Like

The Future of Blockchain: Knightsbridge KXCO Leads the Way

Knightsbridge Unveils Security Strategy for KXCO Armature: A Trusted Solution for Global Financial Institutions

The Corruption of Politicians and Media Lies Are Destroying Society

KXCO Chain: A Scam-Free Blockchain Ecosystem

China’s Economic Resilience

TAGGED:biotechcancercashPBYIresistancesupport

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

Subscribe our newsletter for latest news around the world. Let's stay updated!

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
By Paul Ebeling
Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   
Previous Article Wall Street’s Key Stock Analysts Research Reports, All Buys
Next Article Portfolio Builder for Conservative Investors


Latest News

Quantum Computing, AI, and Bitcoin: Knightsbridge and the New Frontier in Digital Finance
AI Artificial Intelligence Bitcoin Blockchain Blockchain for Government Generative AI Headline News Knightsbridge KXCO Opinion Shayne Heffernan May 23, 2025
Saudi Arabia Non-Oil Sector Soars to 54.8% of GDP
Headline News Middle East Opinion Politics Shayne Heffernan Shayne Heffernan May 23, 2025
The Case for Blockchain Efficiencies in Securities Markets
Bitcoin Blockchain for Government cefi DeFI Digital Assets Headline News Knightsbridge Opinion May 23, 2025
shayne heffernan saudi
Saudi Arabia Climbs to 2nd in G20 ICT Regulatory Index
Featured Headline News Middle East Most Popular Must Read Opinion Saudi Arabia Shayne Heffernan May 22, 2025

Stay Connected

235.3kFollowersLike
69.1kFollowersFollow
11.6kFollowersPin
56.4kFollowersFollow
4.4kFollowersFollow
//

Stay informed with LiveTradingNews.com – your ultimate destination for timely and insightful updates on global markets, finance, and investment trends. Explore the latest news and analysis to empower your trading decisions.

Quick Link

  • About us
  • Advertise
  • Send us a tip!
  • Privacy Policy
  • Contact us

Top Categories

  • Knightsbridge Insights
  • Featured
  • Stocks
  • Shayne Heffernan
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Subscribe our newsletter for latest news around the world. Let's stay updated!

Live Trading NewsLive Trading News
Follow US
© 2025 LiveTradingNews - For The Traders, By The Traders – All Right Reserved By Knightsbridge Group
Welcome Back!

Sign in to your account

Register Lost your password?